Loading...

Axsome Therapeutics, Inc.

0HKF.L•LSE
Healthcare
Medical - Pharmaceuticals
£116.47
£0.74(0.64%)

Axsome Therapeutics, Inc. (0HKF.L) Stock Overview

Explore Axsome Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 65.2/100

Key Financials

Market Cap5.7B
P/E Ratio-23.33
EPS (TTM)$-3.72
ROE-3.58%
Fundamental Analysis

AI Price Forecasts

1 Week$114.54
1 Month$121.41
3 Months$133.84
1 Year Target$120.42

0HKF.L Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Axsome Therapeutics, Inc. (0HKF.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 75.48, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $120.42.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -23.33 and a market capitalization of 5.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.09%
5-Day Change
-11.33%
1-Month Change
-21.84%
3-Month Change
16.73%
6-Month Change
11.87%
Year-to-Date (YTD) Change
4.40%
1-Year Change
32.15%
3-Year Change
128.17%
5-Year Change
2685.07%
All-Time (Max) Change
2685.07%

Contact Information

https://www.axsome.com
212 332 3241
22 Cortlandt Street, New York City, NY, 10007

Company Facts

712 Employees
IPO DateJan 29, 2018
CountryUS
Actively Trading

Frequently Asked Questions

;